Physician

Peter J Belin, MD

According to 2025 Medicare claims, Peter Belin, MD (NPI: 1275929259) practices ophthalmology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from Hennepin, MN. This provider's primary affiliated billing organization is VITREO RETINAL SURGERY PLLC (NPI: 1891783965; TIN: 411608615) and primary practice location at 55125-1206.

Belin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 839 traditional Medicare patients, billed 30,043 HCPCS/CPT codes, and received $2,489,956 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 654 prescription claims across 251 beneficiaries totaling $30,542 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 4 records totaling $7,323. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $92,225 to $2,489,956. Similarly, Part D prescription costs have risen steadily, from $2,115 to $30,542. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.5M2020 Medicare payment: $92,225 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $829,403 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,418,088 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,889,755 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,489,956 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020122530$92,225
20215914,464$829,403
20228017,852$1,418,088
202384214,063$1,889,755
202483930,043$2,489,956

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$24K$49K2015 Drug cost: $2,115 (USD; Tot_Drug_Cst)2016 Drug cost: $6,505 (USD; Tot_Drug_Cst)2017 Drug cost: $20,473 (USD; Tot_Drug_Cst)2018 Drug cost: $26,081 (USD; Tot_Drug_Cst)2019 Drug cost: $14,107 (USD; Tot_Drug_Cst)2020 Drug cost: $5,259 (USD; Tot_Drug_Cst)2021 Drug cost: $16,929 (USD; Tot_Drug_Cst)2022 Drug cost: $34,002 (USD; Tot_Drug_Cst)2023 Drug cost: $48,571 (USD; Tot_Drug_Cst)2024 Drug cost: $30,542 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151232$2,115
201653123$6,505
2017103396$20,473
2018104372$26,081
201971184$14,107
202062117$5,259
2021154346$16,929
2022245617$34,002
2023280656$48,571
2024251654$30,542

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1671,384$658
67028Injection of drug into eye3891,495$96
92014Established patient complete exam of visual system300336$88
92012Established patient problem focused exam of visual system371554$64
92134Imaging of retina8192,224$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium30888$6,694
Prednisolone AcetatePrednisolone Acetate1305,925$6,585
Ketorolac TromethamineKetorolac Tromethamine2098,975$4,435
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha1212,594$1,458
Brimonidine TartrateBrimonidine Tartrate161,030$1,345

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$7,323Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Peter J. Belin, MD?

Tedicare shows public-source Medicare data for Peter J. Belin, MD (NPI 1275929259), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Peter J. Belin, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Peter J. Belin, MD?

Peter J. Belin, MD is linked to VITREO RETINAL SURGERY PLLC (billing NPI 1891783965) in the available physician profile data.

Does Peter J. Belin, MD have Open Payments data?

Peter J. Belin, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.